feed,title,long_url,short_url
BioRxiv,A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity,https://biorxiv.org/cgi/content/short/2022.08.03.502672v1?rss=1,https://bit.ly/3d8lXfq
BioRxiv,Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage,https://biorxiv.org/cgi/content/short/2022.08.04.502609v1?rss=1,https://bit.ly/3oX0dG2
BioRxiv,Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents,https://biorxiv.org/cgi/content/short/2022.08.03.499114v1?rss=1,https://bit.ly/3oW0oS0
BioRxiv,Phenotype-driven identification of drug targets for post-COVID-19 anosmia,https://biorxiv.org/cgi/content/short/2022.08.03.502673v1?rss=1,https://bit.ly/3zXl3LH
